Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAST: Avatrombopag in End-stage Liver Disease with Thrombocytopenia
NCT04906083Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of avatrombopag in Thrombocytopenia, sponsored by Tongji Hospital. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT04906083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906083.